FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Par Pharmaceutical Frovatriptan Succinate Tablets Recall

Frovatriptan Succinate Tablets, 2

Par Pharmaceutical Inc. · Chestnut Ridge, NY

Risk level
Class III
Reported by FDA
Feb 19, 2020
Recall ID
D-0843-2020
Check your lot numberHow we source this data

Summary

Par Pharmaceutical recalled Frovatriptan Succinate Tablets starting Feb 10, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0843-2020 on Feb 19, 2020. Reason: Labeling: Incorrect or Missing Lot and/or Exp Date: Product incorrectly labeled with an expiration date of August 2022 rather than the correct expiration date of April 2022. Status: Terminated.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date: Product incorrectly labeled with an expiration date of August 2022 rather than the correct expiration date of April 2022.

Product description

Frovatriptan Succinate Tablets, 2.5mg, packaged in 1 blister card of 9 tablets per carton, Rx Only, Manufactured by: Almac Pharma Services Limited, Craigavon, BT63 5UA, UK; Manufactured for: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 0603-3718-34.

Lot numbers, UPCs & expiration codes

Lot Number: 9698818; labeled expiration AUG 2022; actual expiration APR 2022

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0843-2020
Classification
Class III
Status
Terminated
Recall initiated
Feb 10, 2020
FDA report date
Feb 19, 2020
Quantity
9,936 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Par Pharmaceutical Inc.

Original FDA data

Every field from FDA enforcement report D-0843-2020, exactly as published.

Show all FDA fields
City
Chestnut Ridge
State
NY
Status
Terminated
Country
United States
Event ID
84912
Address
1 Ram Ridge Rd
Code information
Lot Number: 9698818; labeled expiration AUG 2022; actual expiration APR 2022
Postal code
10977-6714
Report date
Feb 19, 2020
Product type
Drugs
Recall number
D-0843-2020
Classification
Class III
Recalling firm
Par Pharmaceutical Inc.
Product quantity
9,936 cartons
Termination date
Nov 17, 2020
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date: Product incorrectly labeled with an expiration date of August 2022 rather than the correct expiration date of April 2022.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Frovatriptan Succinate Tablets, 2.5mg, packaged in 1 blister card of 9 tablets per carton, Rx Only, Manufactured by: Almac Pharma Services Limited, Craigavon, BT63 5UA, UK; Manufactured for: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 0603-3718-34.
Distribution pattern
Nationwide in the USA
Recall initiation date
Feb 10, 2020
Initial firm notification
Letter
Center classification date
Feb 13, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0843-2020, published Feb 19, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls